Volume 17, Number 9—September 2011
Synopsis
Risk-based Estimate of Effect of Foodborne Diseases on Public Health, Greece
Table 2
Disability weights related to the diseases included in study of the effects of foodborne infections, Greece, 1996–2006
| Illness | Disability weights | |
| Reported or estimated cases | Underreported cases | |
| Bacterial | ||
| Botulism | ||
| Moderate cases | 0.600 | 0.600 |
| Severe cases | 0.906 | 0.906 |
| Brucellosis | 0.200 | 0.200 |
| Campylobacteriosis | 0.067 | |
| Gastroenteritis | 0.393 | |
| Reactive arthritis | 0.140 | |
| Guillain-Barré syndrome, first year* | 0.250 | |
| Guillain-Barré syndrome, long-term sequelae | 0.160 | |
| Inflammatory bowel disease | 0.260 | |
| Irritable bowel syndrome | 0.042 | |
| Enterohemorrhagic Escherichia coli | 0.067 | |
| Watery diarrhea and hemorrhagic colitis | 0.393 | |
| Hemolytic uremic syndrome and end-stage renal disease | † | |
| Leptospirosis | 0.920 | 0.096 |
| Listeriosis | ‡ | ‡ |
| Salmonellosis | 0.067 | |
| Gastroenteritis | 0.393 | |
| Inflammatory bowel disease | 0.260 | |
| Irritable bowel syndrome | 0.042 | |
| Reactive arthritis | 0.150 | |
| Shigellosis | 0.220 | 0.096 |
| Irritable bowel syndrome | 0.042 | |
| Typhoid and paratyphoid fever | 0.600 | 0.096 |
| Food poisoning | 0.220 | 0.067 |
| Parasitic | ||
| Amebiasis | 0.400 | 0.067 |
| Cryptosporidiosis | 0.393 | 0.067 |
| Echinococcosis | ||
| Cured | 0.200 | 0.200 |
| Postsurgical conditions | 0.239 | 0.239 |
| Relapse | 0.809 | 0.809 |
| Undiagnosed | 0.200 | 0.200 |
| Giardiasis | 0.393 | 0.067 |
| Toxoplasmosis | ||
| Clinical symptoms in the first year of life§ | 0.140 | ¶ |
| Asymptomatic at birth, chorioretinitis later in life | 0.080 | ¶ |
| Viral: acute hepatitis A | 0.500 | 0.500 |
| Mixed/ill-defined causes | ||
| Other helminthiases | 0.463 | 0.067 |
| Intestinal infections caused by other specified microorganism | 0.400 | 0.067 |
| Ill-defined intestinal infections | 0.400 | 0.067 |
*For an explanation of this selection, see the Technical Appendix.
†For hemolytic uremic syndrome (including end-stage renal disease as a sequela), it is estimated that every case corresponds to 1.05 years lived with disability (24).
‡Not applicable for listeriosis because the high case-fatality rate (>95%) of the disability-adjusted life year estimates is composed of years of life lost (24) that mainly determine the burden of the disease. Therefore, no years lived with disability were estimated.
§Clinical symptoms in the first year of life include chorioretinitis, intracranial calcifications, hydrocephalus, and central nervous system abnormalities that lead to neurologic deficiencies such as mental retardation.
¶Toxoplasmosis cases are estimates for the entire population. Consequently, underreporting does not apply.


